Live Webinar | November 18th at 11am ET | Explore how data volatility affects biopharma companies and proactive strategies to navigate an uncertain environment.
In biopharma, data volatility is an ongoing challenge, disrupting the real-world data (RWD) pipelines that drive critical insights needed to bring therapies to market. Causes for these data disruptions range from cyber threats and evolving regulations to supply chain disruptions and legacy systems, with consequences that reverberate across teams and impact decision-making and commercial strategy.
A recent McKesson Compile survey found that 68% of senior biopharma professionals in commercial roles experienced claims data volatility in the past year, leading to false insights, delayed decisions, and reassessment of data sourcing and management. With 99% expressing concern about future disruptions, proactive strategies are essential. Join industry experts as they explore:
- The impact of disruptions to the healthcare claim data landscape for biopharma companies
- Which claims are most vulnerable and why diversity in data sources matter
- How to identify and address data disruptions in your analyses to minimize their impact
- The benefits of proactive data management and strategy to bolster resilience
Offered Free by: BioPharma Dive’s studioID and McKesson Compile
See All Resources from: BioPharma Dive’s studioID and McKesson Compile
